Uremic serum enhances scavenger receptor expression and activity in the human monocytic cell line U937

Kidney International

Volumn 51, Issue 3, 1997, Pages 785-792

  Ando, Minoru ^a   Gåfvels, Mats ^b   Bergström, Jonas ^b   Lindholm, Bengt ^b   Lundkvist, Inger ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; SCAVENGER RECEPTOR;

ADULT; ARTICLE; ATHEROGENESIS; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; MONOCYTE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; UREMIA;

EID: 0030887030     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.110     Document Type: Article

References (41)

1. BROWN MS, GOLDSTEIN JL: Lipoprotein metabolism in macrophages. Ann Rev Biochem 52:223-261, 1983
2. ROSS R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-809, 1993
3. GOLDSTEIN JL, HO YK, BASU S, BROWN MS: Binding site of macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition. Proc Natl Acad Sci USA 76:333, 1979
4. STEINBERG D, PARTHASARATHY S, CAREW TE, KHOO JC, WITZTUM JL: Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924, 1989
5. NAITO M, SUZUKI H, MORI T, MATSUMOTO A, KODAMA T, TAKAHASHI K: Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am J Pathol 141:591-599, 1992
6. FRASER I, HUGHES D, GORDON S: Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature 364:343-346, 1993
7. VIA DP, PONS L, DENNISON DK, FANSLOW AE, BERNINI F: Induction of acetyl-LDL receptor activity by phorbol ester in human monocyte cell line THP-1. J Lipid Res 30:1515-1524, 1989
8. VAN LENTEN BJ, FOGELMAN AM, SEAGER J, RIBI E, HABERLAND ME, EDWARDS PA: Bacterial endotoxin selectively prevents the expression of scavenger-receptor activity on human monocyte-macrophages. J Immunol 134:3718-3721, 1985
9. ISHIBASHI S, INABA T, SHIMANO H, HARADA K, INOUE I, MOKUNO H, MORI N, GOTODA T, TAKAKU F, YAMADA N: Monocyte-colony-stimulating factor enhances uptake and degradation of acetylated low density lipoproteins and cholesterol esterification in human monocyte-derived macrophage. J Biol Chem 235:14109-14117, 1990
10. FUHRMAN B, BROOK GJ, AVIRAM M: Activated platelets secrete a protein-like factor that stimulates oxidized-LDL receptor activity in macrophages. J Lipid Res 32:1113-1123, 1991
11. BOTTALICO LA, WAGER RE, AGELLON LB, ASSOIAN RK, TABAS I: Transforming growth factor-β1 inhibits scavenger receptor activity in THP-1 human macrophages. J Biol Chem 266:22866-22871, 1991
12. GENG YJ, HANSSON G: Interferon-γ inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest 89:1322-1330, 1992
13. VAN LENTEN BJ, FOGELMAN AM: Lipopolysaccharidc-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-α. J Immunol 148:112-116, 1992
14. UNANUE ER: Macrophages, antigen-presenting cells, and the phenomena of antigen handling and presentation, in Fundamental Immunology, edited by WILLIAM EP, New York, Raven Press, Ltd., 1993, p 111
15. DE VILLIERS WJS, FRASER IP, HUGHES DA, DOYLE AG, GORDON S: Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function. J Exp Med 180: 705-709, 1994
16. KAWANO Y, TAKAUE Y, MOTOYOSHI K, MINUKUCHI J, KAWASHIMA S, SAITO S, HIRAO A, SHIMIZU T, KURODA Y: Measurement of serum levels of macrophage colony-stimulating factor (M-CSF) in patients with uremia. Exp Hematol 21:220-223, 1993
17. SATO H, OHKUBO M, NAGAOKA T: Levels of serum colony-stimulating factors (CSFs) in patients on long-term haemodialysis. Cytokine 6:187-194, 1994
18. LINDNER A, CHARRA B, SHERRARD DJ, SURIBNER BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697-701, 1974
19. KUDOH Y, IMMURA O: Study on the atherosclerosis mechanisms in chronic hemodialysis. Jpn Circ J 51:631-641, 1987
20. ROSTRAND SG, GRETES JC, KIRK KA, RUTSKY EA: Relationship of coronary risk factor to hemodialysis-associated ischemic heart disease. Kidney Int 22:304-308, 1982
21. BROWN JH, HUNT LP, VITES NP, SHORT CD, GOKAL R, MALLICK NP: Comparative mortality from cardiovascular disease in patients with chronic failure. Nephrol Dial Transplant 9:1136-1142, 1994
22. MAGGI E, BELLAZZI R, FRANCESCO F, FRATTONI A, PERANI G, FINARDI G, GAZO A, NAI M, ROMANINI D, BELLOMO G: Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis? Kidney Int 45:876-883, 1994
23. MAGGI E, BELLAZZI R, GAZO A, SECCIA M, BELLOMO G: Antibodies against oxidatively-modified LDL in uremic patients undergoing dialysis. Kidney Int 46:869-876, 1994
24. ANDO M, LUNDKVIST I, BERGSTRÖM J, LINDHOLM B: Enhanced scavenger receptor expression in monocyte-macrophages in dialysis patients. Kidney Int 49:773-780, 1996
25. DINARELLO CA: Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis. Kidney Int 42(Suppl 38):S68-S77, 1992
26. KODAMA T, REDDY P, KISHIMOTO C, KRIEGER M: Purification and characterization of a bovine acetyl low density lipoprotein receptor. Proc Natl Acad Sci USA 85:9238-9242, 1988
27. GIANTURCO SH, RAMPRASAD MP, LIN AH-Y, SONG R, BRADLEY W: Cellular binding site and membrane binding proteins for triglyceride-rich lipoproteins in human monocyte-macrophages and THP-1 monocytic cells. J Lipid Res 35:1674-1687, 1994
28. BRADFORD MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-255, 1976
29. 4. Nature 227:680-685, 1970
30. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
31. HANAMUKA T, MOTOYOSH K, YOSHIDA K, SAITO M, MIURA Y, KAWASHIMA T, NISHIDA M, TAKAKU F: Quantitation and identification of human monocytic colony-stimulating factor in human serum by enzyme-linked immunosorbent assay. Blood 72:886-892, 1988
32. AKESSON AL, SCHROEDER K, WOODS C, SCHMIDT CJ, JONES WD: Suppression of interleukin-1β and LDL scavenger receptor expression in macrophages by selective protein kinase C inhibitor. J Lipid Res 32:1699-1707, 1991
33. SUZUKI K, SAKATA N, KITANI A, HARA M, HIROSE T, HIROSE W, NORIOKA K, HARIGAI M, KAWAGOE M, NAKAMURA H: Characterization of human monocytic cell line, U937, in taking up acetylated low-density lipoprotein and cholesteryl ester accumulation. A flow cytometric and HPLC study. Biochim Biophys Acta 1042:210-216, 1990
34. PITAS RE: Expression of the acetyl low density lipoprotein receptor by rabbit fibroblasts and smooth muscle cells. J Mol Chem 265:12722-12727, 1990
35. GREEN D, STONE NJ, KRUMLOVSKY FA: Putative atherogenic factors in patients with chronic renal failure. Prog Cardiovasc Dis 26:133-144, 1983
36. MENDELSOHN ME, LOSCALZO J: Role of platelets in cholesteryl ester formation by U937 cells. J Clin Invest 81:62-68, 1988
37. SINGH RK, SINGH SM, SODHI A: Effect of cisplatin treatment of human monocyte cell line U937 on the induction of tumoricidal activity. Neoplasma 39:137-140, 1992
38. BOHBOT A, EISCHEN A, FELDEN C, VINCENT F, OBERLING F: U937 cell line: Impact of CSFs, IL-6 and IFN-gamma on the differentiation and the Leu-CAM proteins expression. Exp Hematol 21:564-572, 1993
39. VOYTA JC, VIA DP, BUTTERFIELD CE, ZETTER BR: Identification and isolation of endothelial cells based on their increased uptake of acetyl-low density lipoprotein. J Cell Biol 99:2034-2040, 1984
40. CURTISS LK, BLACK AS, TAKAGI Y, PLOW EF: New mechanism for foam cell generation in atherosclerotic lesions. J Clin Invest 80:367-373, 1987
41. REVERTER JC, ESCOLAR G, SANZ C, CASES A, VILLAMOR N, NIEUWUNHUIS HK, LOPEZ J, ORDINAS A: Platelet activation during hemodialysis measured through exposure of P-selectin: Analysis by flow cytometric and ultrastructural techniques. J Lab Clin Med 124:79-85, 1994